Abstract:Objective To investigate the effects of minocycline, a neuroinflammation inhibitor, on the depressive behaviors and neurotransmitters in the vascular depression mice model. <br> Methods Male CD1 mice were subject to repeated common carotid artery occlusion and reperfusion to establish the vascular depression model, then randomly divided into experimental group (n=10), control group (n=10) and sham group (n=10). Minocycline (30 mg/kg, i.p.) and same dose of saline were administrated immediately after the surgery and subsequently the consecutive 6 days in experimental group and control group respectively. Mice in sham group were conducted the same surgery expect occluding carotid artery, then administered the same dose of saline as the control group. After the administration, tail suspension test and open-ifeld test were used to assess depression behaviors of mice on the post operation day (POD) 8 and 9 respectively, and Morris water maze was used to assess cognitive function on the POD 10. On POD 11, mice were deeply anesthetized and euthanized and transcardially perfused with phosphate buffered saline (PBS). Expressions of tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) in hippocampus were measured by enzyme-linked immunosorbent assay (ELISA) kit. Contents of 5-hydroxytryptamine (5-HT), norepinephrine (NE) and dopamine (DA) were measured by high performance liquid chromatography (HPLC). <br> Results Among the three groups, the immobility time was signiifcantly different ([174.75±11.37]s vs [194.32±14.32]s vs [169.62±19.27]s, F=6.59, P=0.005), and the immobility time of experimental group and sham group was shorter than control group significantly. The times of exploring holes, prolonged time and distance of movement were signiifcantly different (F=6.17, P=0.008;F=11.55, P<0.001;F=13.47, P<0.001), the times of exploring holes of experimental group and sham group was more than control group signiifcantly, and so did both prolonged time and distance of movement of those two groups. But there was significant difference in escape latency ([87.38±13.36]s vs [88.50±19.88]s vs [44.38±19.76]s, F=16.09, P<0.001) among the three groups, the escape latency of experimental group and control group was signiifcantly longer than sham group. The expression of TNF-α, IL-1βand IL-6 in hippocampus were down-regulated in experimental group and sham group compared with control group (TNF-α:[141.10±24.36]pg/100 mg vs [167.6±15.91]pg/100 mg vs [123.8±15.53]pg/100 mg, F=13.42, P<0.001;IL-6:[20.01±3.62]pg/mg vs [24.39±5.04]pg/mg vs [18.40±3.78]pg/mg, F=5.49, P=0.010;IL-1β([5.32±1.89]pg/mg vs [10.31±2.83]pg/mg vs [4.50±2.07] pg/mg, F=18.69, P<0.001). There were no signiifcant difference in the level of NE among the three groups ([3.97±1.35]ng/ml vs [3.16±1.55]ng/ml vs [4.68±1.99]ng/ml, F=2.13, P=0.139), but there is a increased level of DA in experimental group and sham group compared with control group ([10.72±2.65] ng/ml, [11.76±3.10] ng/ml vs [7.99±2.31] ng/ml). <br> Conclusion Minocycline can restrain the expression of inflammatory cytokines in vascular depression mice, and inhibited inflammation may improve their depression behaviors, but no improvement found in the cognitive impairment. Among those relevant neurotransmitters, the content of DA changes most signiifcantly.

Minocycline Relieves Depressive-Like Behaviors in Rats with Bone Cancer Pain by Inhibiting Microglia Activation in Hippocampus

Minocycline‐induced Reduction of Brain‐derived Neurotrophic Factor Expression in Relation to Cancer‐induced Bone Pain in Rats

Basolateral Amygdala Reactive Microglia May Contribute to Synaptic Impairment and Depressive-Like Behavior in Mice with Bone Cancer Pain

Minocycline Reduces Intracerebral Hemorrhage-Induced Brain Injury

Microglia Promote Inhibitory Synapse Phagocytosis in the Spinal Cord Dorsal Horn and Modulate Pain-Like Behaviors in a Murine Cancer-Induced Bone Pain Model

Inhibition of microglia activation affected the maintenance of cancer pain in a murine model

MHC-I in the hippocampus promotes comorbid depressive symptoms in bone cancer pain via the upregulation of microglial TREM2/DAP12 signaling

Spared Nerve Injury Increases the Expression of Microglia M1 Markers in the Prefrontal Cortex of Rats and Provokes Depression-Like Behaviors.

Minocycline alleviates depression-like symptoms by rescuing decrease in neurogenesis in dorsal hippocampus via blocking microglia activation/phagocytosis

Minocycline alleviates abnormal microglial phagocytosis of synapses in a mouse model of depression

Minocycline Abrogates Individual Differences in Nerve Injury-Evoked Affective Disturbances in Male Rats and Prevents Associated Supraspinal Neuroinflammation

Fluoxetine Attenuates Pain-Like and Depression-Related Behaviors Via Reducing Neuroinflammation and Synaptic Deficits in Bone Cancer Mice

Effect of hippocampal microglial activation in neuropathic pain-induced cognitive dysfunction

Minocycline Ameliorates Depressive-Like Behavior and Demyelination Induced by Transient Global Cerebral Ischemia by Inhibiting Microglial Activation

Minocycline Improves the Depressive Behaviors of Vascular Depression Mice and Influences the Neurotransmitters Content in Hippocampus via Restraining Neuroinlfammation

Inhibition of Glial Activation in Rostral Ventromedial Medulla Attenuates Mechanical Allodynia in a Rat Model of Cancer-Induced Bone Pain

Chronic Minocycline Treatment Exerts Antidepressant Effect, Inhibits Neuroinflammation, and Modulates Gut Microbiota in Mice

Delayed Activation of Spinal Microglia Contributes to the Maintenance of Bone Cancer Pain in Female Wistar Rats Via P2X7 Receptor and IL-18

Relief of mechanical allodynia in rat model of bone cancer by intrathecal MCP-1 neutralizing antibody

Minocycline Prevents the Depressive-Like Behavior Through Inhibiting the Release of HMGB1 from Microglia and Neurons.

The Microglial Activation Inhibitor Minocycline, Used Alone and in Combination with Duloxetine, Attenuates Pain Caused by Oxaliplatin in Mice